Pharmaceutical & Biotech Companies

Pharmaceutical & Biotech Companies

The best routes for the best therapies

There is a social contract between pharmaceutical companies and the people who need their products. While the access to medicine problem is multifaceted, and responsibility for tackling it lies with many different actors, pharmaceutical and biotech companies clearly have a crucial role to play in finding more routes to ethically expand the access to their launched therapies.

Staggered launching of innovative treatments will trigger patient unmet medical needs in non-launched countries, whereas as a matter of common practice prescribers seek access to the best available treatments for their patients.

HOW WE SUPPORT ACCESS FOR

PHARMACEUTICAL AND BIOTECH COMPANIES

FarmaMondo is facilitating paid access to medicines for more than 100 years. Our country-specific methodologies allow us to closely interact with healthcare providers who represent those highly targeted groups of patients with unmet patient needs. We receive constant flow of spontaneous requests for unlicensed paid access from HCPs globally and we work towards fulfilling every access case in a timely and compliant manner. Pharmaceutical and Biotech companies can opt to make their therapies available for spontaneous unlicensed access requests through FarmaMondo Global Access operations or to initiate a centralized access program through FarmaMondo Managed Access operations.

The best routes for the best therapies

There is a social contract between pharmaceutical companies and the people who need their products. While the access to medicine problem is multifaceted, and responsibility for tackling it lies with many different actors, pharmaceutical and biotech companies clearly have a crucial role to play in finding more routes to ethically expand the access to their launched therapies.

Staggered launching of innovative treatments will trigger patient unmet medical needs in non-launched countries, whereas as a matter of common practice prescribers seek access to the best available treatments for their patients.

HOW WE SUPPORT ACCESS FOR

PHARMACEUTICAL AND BIOTECH COMPANIES

FarmaMondo is facilitating paid access to medicines for more than 100 years. Our country-specific methodologies allow us to closely interact with healthcare providers who represent those highly targeted groups of patients with unmet patient needs. We receive constant flow of spontaneous requests for unlicensed paid access from HCPs globally and we work towards fulfilling every access case in a timely and compliant manner. Pharmaceutical and Biotech companies can opt to make their therapies available for spontaneous unlicensed access requests through FarmaMondo Global Access operations or to initiate a centralized access program through FarmaMondo Managed Access operations.

FOLLOW US ON